Research News and Research

RSS

Hyland Software's OnBase rated as one of the top DMI system solutions on the market

Your healthcare organization is in the market for a document management and imaging (DMI) system. There are dozens of vendors in the space, and each offers something at least slightly different than the others. It's a huge investment and there isn't room for error. Where do you begin your search for a standout vendor and product? Perhaps with a new report from KLAS titled, "Enterprise DMI: Finding the Right Stepping-Stone to Full EMR."

12 Nov 2009

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

A new study from the University of Warwick has discovered taking too much of the essential mineral selenium in your diet can increase your cholesterol by almost 10%.

12 Nov 2009

Gene within the pancreas affecting insulin secretion discovered

How a specific gene within the pancreas affects secretion of insulin has been discovered by researchers from the Hebrew University of Jerusalem, in collaboration with Japanese and American universities. Their work opens the way for a new understanding of possible paths to battle diabetes and diabetes-related health problems, which are on the rise all over the world.

12 Nov 2009

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, is providing an update on its RNAi pipeline, platform, and technology at its R&D Day being held in New York today.

12 Nov 2009

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

Spectrum Pharmaceuticals, Inc., a commercial-stage biotechnology company with a primary focus in oncology, today reported financial results for the third quarter ended September 30, 2009.

12 Nov 2009

Arrayit Diagnostics develops diagnostic tests for early cancer detection

Arrayit Corporation announced today that the company's majority owned subsidiary, Arrayit Diagnostics, Inc., will launch the most intensive marketing campaign in the company's thirteen-year history. The company is currently developing several diagnostic tests that will provide early detection for cancers, neurodegenerative diseases and other disease states.

12 Nov 2009

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

Bradmer Pharmaceuticals Inc. today announced its 2009 third quarter financial results.

12 Nov 2009

"Doctors Speak Out" series to discuss today's health issues

How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today’s most pressing health issues.

12 Nov 2009

LAB Research announces financial results for the third quarter of 2009

LAB Research Inc., a global Canadian-based non-clinical contract research organization, today announced its 2009 third quarter financial results.

12 Nov 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers.

12 Nov 2009

Oxytocin hormone affects behaviors, finds new study

A new study carried out at the University of Haifa has found that oxytocin, also known as the "love hormone", which affects behaviors such as trust, empathy and generosity, also affects opposite behaviors, such as jealousy and gloating.

12 Nov 2009

Frequent heartburn is painful and impacts the quality of life: Study

While most adults have likely experienced the uncomfortable symptoms of heartburn at least once, for the 50 million American adults who suffer from frequent heartburn two or more days per week, the condition is not only painful, it can also impact their quality of life.

12 Nov 2009

Contact lenses prescribed for longer replacement intervals can lead to undesirable clinical outcomes

Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable clinical effects, new research shows.

12 Nov 2009

Gene variants which influence insulin metabolism can also affect birth weight

Low birth weight increases the risk of developing type 2 diabetes later in life. Until recently scientists had attributed this to maternal malnutrition during pregnancy. However, now it seems that genetic background may also play a major role. A research team of Technische Universität München and Helmholtz Zentrum München has now demonstrated, that gene variants which influence insulin metabolism can also affect birth weight.

12 Nov 2009

ORC Guideline's recent research on the impact of social media and pharmaceutical marketing

Chief Research Officer Morris S. Whitcup, Ph.D., of ORC Guideline (an infoGROUP company) (NASDAQ: IUSA) will present findings of the company’s recent research on the impact of social media on fair balance and pharmaceutical marketing at a Food and Drug Administration (FDA) public hearing later this week. The hearing will address the issue of fulfilling requirements for fair balance and risk disclosure in internet and social media promotions. The ORC Guideline study examined consumer habits in researching information about pharmaceutical products online.

12 Nov 2009

NOAA scientists and community leaders to discuss chemicals of concern in coastal waters

This panel brings together leading NOAA scientists and community leaders to discuss research and monitoring of chemicals of concern that enter our coastal waters through run-off, discharge, and other means. With roughly 85,000 chemicals in commercial use in the United States, scientists face major challenges in trying to identify how pervasive these chemicals are in our waters or the potential health impacts they pose to marine wildlife and people.

12 Nov 2009

Stelara expected to change dermatologists’ prescribing habits and alter patient flow models

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Centocor Ortho Biotech's Stelara, the first interleukin (IL)-12/23 inhibitor to enter the psoriasis drug market in the U.S., is expected to change the prescribing habits of dermatologists and substantially alter patient flow to currently marketed biologic agents, including Amgen's Enbrel and Abbott's Humira.

12 Nov 2009

IACC to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research

Autism Speaks is encouraged by yesterday's decision of the Interagency Autism Coordinating Committee (IACC) to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research. The new language, approved unanimously, calls for studies to determine if there are sub-populations that are more susceptible to environmental exposures such as immune challenges related to naturally occurring infections, vaccines or underlying immune problems.

12 Nov 2009

ADOA praises APHA for passing landmark Elimination of Asbestos Resolution

The Asbestos Disease Awareness Organization (ADAO) applauds the American Public Health Association (APHA), the largest and most diverse public health organization in the world.

12 Nov 2009

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

Four macaque monkeys that received injections of genes for a protein called follistatin into upper leg muscles experienced pronounced and durable increases in muscle size and strength and no adverse effects, the Muscular Dystrophy Association (MDA) announced today. The findings could have implications particularly for injured and aging people worldwide; and for tens of millions experiencing muscle loss associated with cancer, AIDs and muscle diseases.

12 Nov 2009

Research News and Research

Hyland Software's OnBase rated as one of the top DMI system solutions on the market

Artificially increasing selenium status above the level required is unwarranted, study calls for further research

Gene within the pancreas affecting insulin secretion discovered

Update on Alnylam Pharmaceuticals' RNAi pipeline, platform, and technology

Spectrum Pharmaceuticals reports consolidated revenues of $7.1M for the third quarter of 2009

Arrayit Diagnostics develops diagnostic tests for early cancer detection

Bradmer Pharmaceuticals reports financial results for the third quarter of 2009

"Doctors Speak Out" series to discuss today's health issues

LAB Research announces financial results for the third quarter of 2009

Tobira Therapeutics presents data on TBR-652 at the European AIDS Conference

Oxytocin hormone affects behaviors, finds new study

Frequent heartburn is painful and impacts the quality of life: Study

Contact lenses prescribed for longer replacement intervals can lead to undesirable clinical outcomes

Gene variants which influence insulin metabolism can also affect birth weight

ORC Guideline's recent research on the impact of social media and pharmaceutical marketing

NOAA scientists and community leaders to discuss chemicals of concern in coastal waters

Stelara expected to change dermatologists’ prescribing habits and alter patient flow models

IACC to include vaccine research studies in the objectives of the updated Strategic Plan for Autism Research

ADOA praises APHA for passing landmark Elimination of Asbestos Resolution

Gene therapy increases muscle size and strength with no adverse effects in monkeys: MDA

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest Life Science News